As of 2026-07-04, the Relative Valuation of Cytokinetics Inc (CYTK) is (132.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 86.49 USD, the upside of Cytokinetics Inc based on Relative Valuation is -253.7%.
The range of the Relative Valuation is (120.54) - (144.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 25.9x | 21.8x |
| Forward P/E multiples | 19.7x - 23.6x | 21.6x |
| Fair Price | (120.54) - (144.41) | (132.93) |
| Upside | -239.4% - -267.0% | -253.7% |
| Date | P/E |
| 2026-06-29 | -14.26 |
| 2026-06-26 | -13.43 |
| 2026-06-25 | -13.20 |
| 2026-06-24 | -13.27 |
| 2026-06-23 | -13.08 |
| 2026-06-22 | -12.94 |
| 2026-06-18 | -12.87 |
| 2026-06-17 | -12.77 |
| 2026-06-16 | -12.29 |
| 2026-06-15 | -11.67 |
| 2026-06-12 | -11.46 |
| 2026-06-11 | -11.32 |
| 2026-06-10 | -10.96 |
| 2026-06-09 | -11.19 |
| 2026-06-08 | -11.10 |
| 2026-06-05 | -11.68 |
| 2026-06-04 | -11.81 |
| 2026-06-03 | -11.56 |
| 2026-06-02 | -11.59 |
| 2026-06-01 | -12.04 |
| 2026-05-29 | -12.54 |
| 2026-05-28 | -12.55 |
| 2026-05-27 | -12.61 |
| 2026-05-26 | -12.47 |
| 2026-05-22 | -12.57 |
| 2026-05-21 | -12.76 |
| 2026-05-20 | -12.87 |
| 2026-05-19 | -12.49 |
| 2026-05-18 | -12.29 |
| 2026-05-15 | -12.40 |
| 2026-05-14 | -12.85 |
| 2026-05-13 | -12.62 |
| 2026-05-12 | -12.23 |
| 2026-05-11 | -12.19 |
| 2026-05-08 | -12.57 |
| 2026-05-07 | -12.14 |
| 2026-05-06 | -12.23 |
| 2026-05-05 | -12.60 |
| 2026-05-04 | -10.79 |
| 2026-05-01 | -10.35 |
| 2026-04-30 | -10.45 |
| 2026-04-29 | -9.74 |
| 2026-04-28 | -9.92 |
| 2026-04-27 | -10.07 |
| 2026-04-24 | -10.67 |
| 2026-04-23 | -10.70 |
| 2026-04-22 | -10.83 |
| 2026-04-21 | -10.75 |
| 2026-04-20 | -10.81 |
| 2026-04-17 | -10.90 |